Literature DB >> 27796148

The potential use of urine cell free DNA as a marker for cancer.

Samanta Salvi1, Filippo Martignano1, Chiara Molinari1, Giorgia Gurioli1, Daniele Calistri1, Ugo De Giorgi2, Vincenza Conteduca2, Valentina Casadio1.   

Abstract

INTRODUCTION: Although the role of circulating cell free DNA in cancer has been widely demonstrated, less is known about the role of urine cell free DNA (UcfDNA). UcfDNA can serve as a 'liquid biopsy' for urological and non-urological tumors, as it carries information on DNA from cells exfoliated in urine and from circulation. Areas covered: We review the studies on UcfDNA as a source of biomarkers for cancer, focusing on the new techniques and the differences between urological and non-urological tumors. We searched Pubmed for articles published between 1998 and 2016 with the following key words and phrases: 'urine' and 'cell free DNA' or 'liquid biopsy' or 'cancer'. Expert commentary: Despite the few papers published on this topic, UcfDNA is an important component of 'liquid biopsy', a useful and non-invasive tool for cancer diagnosis, prognosis and treatment monitoring, containing a wide range of genetic information.

Entities:  

Keywords:  Urine; cancer; cell free DNA; liquid biopsy; markers

Mesh:

Substances:

Year:  2016        PMID: 27796148     DOI: 10.1080/14737159.2016.1254551

Source DB:  PubMed          Journal:  Expert Rev Mol Diagn        ISSN: 1473-7159            Impact factor:   5.225


  13 in total

1.  Utility of liquid biopsy using urine in patients with pancreatic ductal adenocarcinoma.

Authors:  Hiroyuki Terasawa; Hideaki Kinugasa; Soichiro Ako; Mami Hirai; Hiroshi Matsushita; Daisuke Uchida; Takeshi Tomoda; Kazuyuki Matsumoto; Shigeru Horiguchi; Hironari Kato; Kazuhiro Nouso; Hiroyuki Okada
Journal:  Cancer Biol Ther       Date:  2019-07-22       Impact factor: 4.742

2.  [Urinary long non-coding RNA H19 may serve as a biomarker for early diagnosis of acute intestinal necrosis].

Authors:  Yulei Dai; Lubin Yan; Jieling Fan; Qi Zou
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2018-07-30

Review 3.  Current and Emerging Applications of Droplet Digital PCR in Oncology.

Authors:  Susana Olmedillas-López; Mariano García-Arranz; Damián García-Olmo
Journal:  Mol Diagn Ther       Date:  2017-10       Impact factor: 4.074

4.  6-gene promoter methylation assay is potentially applicable for prostate cancer clinical staging based on urine collection following prostatic massage.

Authors:  Kostyantyn A Nekrasov; Mark V Vikarchuk; Evgeniya E Rudenko; Igor V Ivanitskiy; Viacheslav M Grygorenko; Rostyslav O Danylets; Alexander G Kondratov; Liubov A Stoliar; Bizhan R Sharopov; Volodymyr I Kashuba
Journal:  Oncol Lett       Date:  2019-10-29       Impact factor: 2.967

Review 5.  Urinary Biomarkers in Tumors: An Overview.

Authors:  Ilaria Cimmino; Sara Bravaccini; Claudio Cerchione
Journal:  Methods Mol Biol       Date:  2021

Review 6.  Clinical applications of urinary cell-free DNA in cancer: current insights and promising future.

Authors:  Tian Lu; Jinming Li
Journal:  Am J Cancer Res       Date:  2017-11-01       Impact factor: 6.166

Review 7.  Toward urinary cell-free DNA-based treatment of urothelial carcinoma: a narrative review.

Authors:  Yujiro Hayashi; Kazutoshi Fujita
Journal:  Transl Androl Urol       Date:  2021-04

Review 8.  Kinetics of circulating cell-free DNA for biomedical applications: critical appraisal of the literature.

Authors:  Sonia Khier; Laura Lohan
Journal:  Future Sci OA       Date:  2018-02-23

Review 9.  Urine as a Source of Liquid Biopsy for Cancer.

Authors:  Masanori Oshi; Vijayashree Murthy; Hideo Takahashi; Michelle Huyser; Maiko Okano; Yoshihisa Tokumaru; Omar M Rashid; Ryusei Matsuyama; Itaru Endo; Kazuaki Takabe
Journal:  Cancers (Basel)       Date:  2021-05-28       Impact factor: 6.639

10.  Urine cell-free DNA as a promising biomarker for early detection of non-small cell lung cancer.

Authors:  Sai Ren; Xiao-Dong Ren; Li-Fang Guo; Xue-Mei Qu; Mei-Yun Shang; Xiao-Tian Dai; Qing Huang
Journal:  J Clin Lab Anal       Date:  2020-04-13       Impact factor: 2.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.